“…Literature concludes that TLM can be considered an established therapeutic option for selected advanced T stage laryngeal tumours, based on good oncologic, functional and economic considerations with an organ preservation rate over 60% in the vast majority of cases [4,16,55,56]. In case of laryngeal tumours involving or originating from the anterior commissure (AC), difficulties in treatment could be related to tumour exposure and technical limitations of lack of perpendicular laser tool, which could be minimised by an enlarged resection and advanced surgical experience with TLM which allow the achievement of comparable oncologic and functional results with low morbidity [24,34].…”
“…Literature concludes that TLM can be considered an established therapeutic option for selected advanced T stage laryngeal tumours, based on good oncologic, functional and economic considerations with an organ preservation rate over 60% in the vast majority of cases [4,16,55,56]. In case of laryngeal tumours involving or originating from the anterior commissure (AC), difficulties in treatment could be related to tumour exposure and technical limitations of lack of perpendicular laser tool, which could be minimised by an enlarged resection and advanced surgical experience with TLM which allow the achievement of comparable oncologic and functional results with low morbidity [24,34].…”
“…in contrast, both transoral robotic surgery (Tors) and transoral laser microsurgery use natural access through the oral cavity and do not damage soft tissues of the neck 4,5 . The benefits of the latter operation are well known.…”
Background. This study compared the adverse effects of open surgery (OS) including lateral pharyngotomy and supraglottic laryngectomy vs. transoral robotic surgery (TORS) in the treatment of stage T1 and T2 carcinomas of the tongue base and supraglottis. Methods. A retrospective study involving a 49 (13 female and 36 male) patients with untreated T1 or T2 carcinomas. Twenty two were operated on using TORS and 27 underwent conventional OS. The indicators for comparison were: total blood loss during surgery, post-operative pain measured with the Visual Analog Scale (VAS); global, emotional and physical post-operational states assessed with the standardized M.D. Anderson Dysphagia Inventory (MDADI) and psychosocial distress (PD) questionnaire. Apart from blood loss, subjective symptoms were evaluated 1 and 6 weeks and 6 months after surgery. The differences in indicators between groups were analyzed using Fisher's Least Significant Difference (LSD) test at the 5% significance level. Results. Mean general OS and TORS associated blood loss were 405 and 29 ml, respectively. The mean MDADI score in TORS vs. OS patients one week, six weeks and six months postoperatively was 60.01 vs. 44.93, 91.01 vs. 62.19 and 94.18 vs. 93.56. The mean VAS score in the TORS vs. OS group at the same time intervals were 5.09 vs. 5.56, 2.09 vs. 3.11 and 1.27 vs. 1.33. All differences between TORS and OS were statistically significant with the exception of 6 month values for particular scores. The mean PD score in TORS vs. OS patients in one week, six weeks and 6 months was 26.82 vs. 25.11, 39.95 vs. 29.22 and 44.73 vs. 44.52. Only the six week distinctions were significant. The both methods were comparable in terms of the risk of locoregional tumour recurrence. Conclusions. The study confirmed the assumption of the TORS as a minimally invasive procedure significantly reducing the intraoperative blood loss, pain, swallowing and psychosocial distress as late as 6 weeks postoperatively in patients with early staged carcinomas of the tongue base and supraglottis.
“…Recent studies demonstrate local control with radiotherapy for T1 glottis neoplasias ranging from 82% to 93%, preserving the larynx in 89% to 96% of cases, and for T2 tumors, 57% to 82% for local control, and preservation of the larynx in 73% to 82% 30 . The rate of relapse with surgical treatment is small and depends on factors such as: involvement of the anterior commissure due to its difficult access site for adequate resection; the ideal laryngeal exposure during the surgical procedure for the various open laryngectomy techniques and for endolaryngeal or trans-oral laser resections; and conditions inherent to the patient 31 . From 1998 on, there was a change in the treatment of laryngeal cancer, with the institution of radiotherapy associated or not with chemotherapy, with the intention of preserving organs, indicated mainly for stages III (T3) 11,32 .…”
RESUMO Objetivo: estudar a condroradionecrose de laringe por complicação de radio-quimioterapia para tratamento do câncer de laringe e propor um fluxograma de tratamento com a utilização de câmara hiperbárica. Métodos: estudo retrospectivo de pacientes portadores de carcinoma de laringe admitidos em dois hospitais terciários num período de cinco anos. Resultados: de 131 pacientes portadores de câncer de laringe, 28 foram submetidos à radio e quimioterapia exclusiva e destes, três evoluíram com condroradionecrose. O tratamento destes pacientes foi realizado com câmara hiperbárica e com desbridamento cirúrgico, conforme proposição do fluxograma. Todos os pacientes tiveram a laringe preservada. Conclusão: a incidência de condroradionecrose de laringe por complicação de radioterapia e quimioterapia em nossa casuística foi de 10,7% e o tratamento com oxigenoterapia hiperbárica, com base no nosso fluxograma, foi efetivo no controle desta complicação.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.